全文获取类型
收费全文 | 3076篇 |
免费 | 396篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 72篇 |
妇产科学 | 57篇 |
基础医学 | 365篇 |
口腔科学 | 52篇 |
临床医学 | 314篇 |
内科学 | 474篇 |
皮肤病学 | 29篇 |
神经病学 | 283篇 |
特种医学 | 67篇 |
外科学 | 536篇 |
综合类 | 101篇 |
一般理论 | 12篇 |
预防医学 | 272篇 |
眼科学 | 221篇 |
药学 | 298篇 |
中国医学 | 1篇 |
肿瘤学 | 290篇 |
出版年
2023年 | 21篇 |
2021年 | 57篇 |
2020年 | 33篇 |
2019年 | 54篇 |
2018年 | 58篇 |
2017年 | 47篇 |
2016年 | 49篇 |
2015年 | 41篇 |
2014年 | 58篇 |
2013年 | 101篇 |
2012年 | 151篇 |
2011年 | 153篇 |
2010年 | 79篇 |
2009年 | 81篇 |
2008年 | 134篇 |
2007年 | 154篇 |
2006年 | 125篇 |
2005年 | 150篇 |
2004年 | 152篇 |
2003年 | 162篇 |
2002年 | 124篇 |
2001年 | 111篇 |
2000年 | 112篇 |
1999年 | 92篇 |
1998年 | 35篇 |
1997年 | 31篇 |
1996年 | 33篇 |
1995年 | 36篇 |
1994年 | 29篇 |
1993年 | 28篇 |
1992年 | 62篇 |
1991年 | 51篇 |
1990年 | 72篇 |
1989年 | 50篇 |
1988年 | 62篇 |
1987年 | 62篇 |
1986年 | 67篇 |
1985年 | 66篇 |
1984年 | 41篇 |
1983年 | 38篇 |
1982年 | 20篇 |
1981年 | 25篇 |
1980年 | 20篇 |
1979年 | 37篇 |
1978年 | 33篇 |
1977年 | 25篇 |
1976年 | 20篇 |
1975年 | 19篇 |
1972年 | 20篇 |
1971年 | 22篇 |
排序方式: 共有3475条查询结果,搜索用时 250 毫秒
61.
Pregash Ellapparadja Yaya Husami Ian McLeod 《European journal of orthopaedic surgery & traumatology : orthopedie traumatologie》2014,24(4):615-619
The posterolateral approach to ankle joint is well suited for ORIF of posterior malleolar fractures. There are no major neurovascular structures endangering this approach other than the sural nerve. The sural nerve is often used as an autologous peripheral nerve graft and provides sensation to the lateral aspect of the foot. The aim of this paper is to measure the precise distance of the sural nerve from surrounding soft tissue structures so as to enable safe placement of skin incision in posterolateral approach. This is a retrospective image review study involving 64 MRI scans. All measurements were made from Axial T1 slices. The key findings of the paper is the safety window for the sural nerve from the lateral border of tendoachilles (TA) is 7 mm, 1.3 cm and 2 cm at 3 cm above ankle joint, at the ankle joint and at the distal tip of fibula respectively. Our study demonstrates the close relationship of the nerve in relation to TA and fibula in terms of exact measurements. The safety margins established in this study should enable the surgeon in preventing endangerment of the sural nerve encountered in this approach. 相似文献
62.
63.
64.
Evaluating the use of plerixafor in stem cell mobilisation – an economic analysis of the PHANTASTIC trial 下载免费PDF全文
Antony P. Martin Sarah Richards Alan Haycox Rachel Houten Claire McLeod Barbara Braithwaite Jack O. Clark Joanne Bell Richard E. Clark 《Journal of clinical apheresis》2016,31(5):434-442
Plerixafor is an effective haematopoietic stem cell mobilising agent in candidates for autologous transplantation, including patients with myeloma and lymphoma. Here we compare 98 plerixafor recipients in the PHANTASTIC trial with 151 historic controls mobilised by conventional chemotherapy (each with granulocyte colony‐stimulating factor, G‐CSF). Seventy (71.4%) plerixafor‐mobilised patients achieved the composite primary endpoint of ≥4 × 106 CD34+ cells kg?1 in ≤2 aphereses and no clinically significant neutropenia, compared to 48 (31.8%) historic controls (P < 0.001), and this significant advantage was maintained in scenario analyses testing components of this composite endpoint. A patient‐level cost analysis was undertaken for 249 patients, which included the cost of remobilising patients where initial mobilisation had failed. Combined mean treatment cost for plerixafor mobilised patients was £12,679 compared with £11,694 for historical controls. However, plerixafor produces an average saving of £3,828 per lymphoma patient but average cost increase by £5,245 per myeloma patient. The present data demonstrate cost‐effectiveness for plerixafor as a first line mobilisation agent, certainly for lymphoma patients, where substantial resource savings and achievement of the primary endpoint are likely. J. Clin. Apheresis 31:434–442, 2016. © 2015 Wiley Periodicals, Inc. 相似文献
65.
66.
67.
68.
Iona Novak 《Developmental medicine and child neurology》2013,55(11):974-974
69.
We report a case of a massive mediastinal teratoma in an 18-year-old woman who presented with a short history of exertional dyspnoea. The tumor arose from the left lobe of the thymus and extended into the left pleural cavity, completely compressing the left lung and extensively shifting the mediastinum to the right. Measuring 23 cm x 17 cm x 9 cm and weighing 2005 g it is one of the largest anterior mediastinal teratomas reported. It was successfully treated by surgical resection, with a final pathological diagnosis of a grades 1-2 immature teratoma. 相似文献
70.
Mark TL Kranzler HR Poole VH Hagen CA McLeod C Crosse S 《The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions》2003,12(4):281-294
In 1994, naltrexone became the first medication approved by the Food and Drug Administration as an adjunct in alcoholism treatment in almost fifty years. Despite evidence of its efficacy, use of naltrexone is not widespread. Patient and physician focus groups were used to identify reasons naltrexone has not been prescribed more widely. Barriers to its widespread use include a lack of awareness, a lack of evidence of efficacy in practice, side effects, time for patient management, a reluctance to take medications, medication addiction concerns, Alcoholics Anonymous (AA) philosophy, and price. The study indicates that medications to treat alcoholism must overcome numerous barriers before becoming widely accepted. 相似文献